1. Metabolic implications of non-electrogenic ATP/ADP exchange in cancer cells: A mechanistic basis for the Warburg effect
   John J. Lemasters, 2021, Biochimica et Biophysica Acta (BBA) - Bioenergetics CrossRef
2. The relative isoform expression levels of isocitrate dehydrogenase in breast cancer: IDH2 is a potential target in MDA-MB-231 cells
   Shuyu Piao et al, 2023, Korean Journal of Clinical Oncology CrossRef
3. A new functional IDH2 genetic variant is associated with the risk of lung cancer
   Jiangjiang Li et al, 2017, Molecular Carcinogenesis CrossRef
4. The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancer
   Abrar I. Aljohani et al, 2020, Breast Cancer Research and Treatment CrossRef
5. Emerging Anti-cancer Targets in Mitochondria
   Petr Ježek et al, 2014, Mitochondria: The Anti- cancer Target for the Third Millennium CrossRef
6. Wild-type IDH2 protects nuclear DNA from oxidative damage and is a potential therapeutic target in colorectal cancer
   Shuang Qiao et al, 2021, Oncogene CrossRef
7. Wild-type IDH2 contributes to Epstein–Barr virus-dependent metabolic alterations and tumorigenesis
   Feng Shi et al, 2020, Molecular Metabolism CrossRef
8. Characterization of pyruvate metabolism and citric acid cycle patterns predicts response to immunotherapeutic and ferroptosis in gastric cancer
   Xu Wang et al, 2022, Cancer Cell International CrossRef
9. Mutation and expression analysis of the IDH1, IDH2, DNMT3A, and MYD88 genes in colorectal cancer
   Wen-Liang Li et al, 2014, Gene CrossRef
10. Proof-of-Concept Workflow for Establishing Reference Intervals of Human Urine Proteome for Monitoring Physiological and Pathological Changes
    Wenchuan Leng et al, 2017, EBioMedicine CrossRef
11. Metformin prevents DMH‐induced colorectal cancer in diabetic rats by reversing the warburg effect
    Yanglei Jia et al, 2015, Cancer Medicine CrossRef
12. IDH2: A novel biomarker for environmental exposure in blood circulatory system disorders (Review)
    Ya Gong et al, 2022, Oncology Letters CrossRef
13. A six-gene prognostic model predicts overall survival in bladder cancer patients
    Liwei Wang et al, 2019, Cancer Cell International CrossRef
14. IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies
    Elisa Bergaggio et al, 2019, Blood CrossRef
15. Serine Biosynthesis Is a Metabolic Vulnerability in IDH2-Driven Breast Cancer Progression
    Georgina D. Barnabas et al, 2021, Cancer Research CrossRef
16. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3
    Xiaoyan Fan et al, 2018, International Journal of Molecular Sciences CrossRef
17. Isocitrate dehydrogenase 2 inhibits gastric cancer cell invasion via matrix metalloproteinase 7
    Dandan Wu, 2016, Tumor Biology CrossRef
18. Downregulation of IDH2 exacerbates the malignant progression of osteosarcoma cells via increased NF-κB and MMP-9 activation
    WAN-RONG YI et al, 2016, Oncology Reports CrossRef
19. Argininosuccinate lyase is a metabolic vulnerability in breast development and cancer
    Sigurdur Trausti Karvelsson et al, 2021, npj Systems Biology and Applications CrossRef
20. Wild-Type IDH Enzymes as Actionable Targets for Cancer Therapy
    Elisa Bergaggio et al, 2019, Cancers CrossRef
21. ASV-ID, a Proteogenomic Workflow To Predict Candidate Protein Isoforms on the Basis of Transcript Evidence
    Seul-Ki Jeong et al, 2018, Journal of Proteome Research CrossRef
22. Overcoming platinum-acquired resistance in ovarian cancer patient-derived xenografts
    Francesca Ricci et al, 2019, Therapeutic Advances in Medical Oncology CrossRef
23. Wild-Type Isocitrate Dehydrogenase-Dependent Oxidative Decarboxylation and Reductive Carboxylation in Cancer and Their Clinical Significance
    Qiwei He et al, 2022, Cancers CrossRef